December 14, 2025
July 14, 2026
This video-based program is designed for eye care professionals to explore the management of neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) using newer anti-VEGF agents with the potential for extended treatment intervals. This program places the patient’s...
Free CE/CME
December 14, 2025
July 14, 2026
This online, on-demand virtual symposium brings together renowned experts in dry eye disease (DED). In this educational program, these experts use a case-based format to discuss the latest data regarding management of this disorder, share their perspectives and best practices,...
Free CE/CME
December 14, 2025
July 14, 2026
With recent additions to treatment options for neovascular age-related macular degeneration (nAMD) come new questions. How can newer anti-VEGF therapies affect the treatment burden for patients with nAMD? Which patients can attain longer treatment intervals, and what are the criteria...
Free CE/CME
December 14, 2025
July 14, 2026
This online, on-demand virtual symposium brings together renowned experts in Demodex blepharitis. In this educational program, these experts review the diagnosis and management of Demodex blepharitis, including a review of available and investigational therapies. This educational activity is an archive...
Free CE/CME
December 14, 2025
July 14, 2026
In this program, a panel of retina specialists share their insights into the use of newer anti-VEGF agents, which offer the opportunity for extended treatment intervals for the treatment of retinal vein occlusion (RVO), neovascular age-related macular degeneration, and diabetic...
Free CE/CME
December 14, 2025
July 14, 2026
Vascular endothelial growth factor (VEGF) is essential in the pathogenesis of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). As such, VEGF inhibitors have become commonly used and effective pharmacologic strategies for both diseases. However, limitations exist, such...
Free CE/CME
December 14, 2025
July 14, 2026
X-linked retinitis pigmentosa (XLRP), which commonly results from mutations in the RPGR gene or the RP2 gene, is frequently more severe than other forms of retinitis pigmentosa. The onset of legal blindness occurs decades earlier in male patients than in...
Free CE/CME
December 14, 2025
July 14, 2026
This online activity is designed to update clinicians on data presented at the American Society of Retina Specialists 43rd Annual Meeting held in Long Beach, CA, from July 30 to August 2, 2025. Expert thought leaders provide insights to help...
Free CE/CME
December 14, 2025
July 14, 2026
This online, on-demand virtual symposium brings together renowned experts in neurotrophic keratitis (NK). In this educational program, these experts discuss the symptoms associated with NK, present video demonstrations of various techniques for corneal sensitivity testing, and share their perspectives and...
Free CE/CME
December 14, 2025
July 14, 2026
Join leading optometrists and ophthalmologists for two days of high-impact education, real-world clinical insights, and meaningful collaboration at EyeCon 2026, taking place September 26–27 at the Margaritaville Hollywood Beach Resort in Hollywood, Florida. Designed for today’s eye care professionals, EyeCon...
Free CE/CME